Offer - Urjas Oil for just ₹ 1 X
Nitroprin 30/75 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Angina, Fever, Heart Attack. The alternative uses of Nitroprin 30/75 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Nitroprin 30/75 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Nitroprin 30/75 Tablet are Headache, Dizziness, Flushing. Besides the aforementioned side effects, there are other adverse effects of Nitroprin 30/75 Tablet as well, which are listed below. These side effects of Nitroprin 30/75 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Nitroprin 30/75 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Nitroprin 30/75 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nitroprin 30/75 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Anemia, Asthma as it can result in adverse effects. Some other conditions that can be affected by Nitroprin 30/75 Tablet are listed in the contraindications section below.
Besides this, Nitroprin 30/75 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Nitroprin 30/75 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Nitroprin 30/75 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nitroprin 30/75 Tablet safe for pregnant women?
Nitroprin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Nitroprin 30/75 Tablet safe during breastfeeding?
Nitroprin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nitroprin 30/75 Tablet on the Kidneys?
Nitroprin can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nitroprin 30/75 Tablet on the Liver?
Nitroprin is not harmful for the liver.
What is the effect of Nitroprin 30/75 Tablet on the Heart?
The heart can be affected by Nitroprin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Nitroprin 30/75 Tablet unless your doctor advises you to do so -
Is this Nitroprin 30/75 Tablet habit forming or addictive?
Nitroprin 30/75 Tablet does not cause addiction.
Interaction between Food and Nitroprin 30/75 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Nitroprin 30/75 Tablet together with food.
Interaction between Alcohol and Nitroprin 30/75 Tablet
Due to lack of research, there is no information about the side effects of taking Nitroprin 30/75 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194